Seoul National University Hospital
Chung-hoon Koo
This study is a randomized, controlled trial. A total of 72 patients will be randomized to receive remimazolam anesthesia or balanced anesthesia (propofol + desflurane) during extracranial-intracranial bypass surgery.
Intraoperative Hypotension
Remimazolam
Balanced Anesthesia
Not Applicable
Study Type : | Interventional |
Estimated Enrollment : | 72 participants |
Masking : | Double |
Primary Purpose : | Prevention |
Official Title : | Effects of Remimazolam on the Intraoperative Hemodynamic Parameters in Patients Undergoing Extracranial-intracranial Bypass Surgery: a Prospective Randomized Controlled Trial |
Actual Study Start Date : | October 20, 2022 |
Estimated Primary Completion Date : | October 30, 2023 |
Estimated Study Completion Date : | December 30, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: remimazolam group General anesthesia is induced and maintained with remimazolam. |
Drug: Remimazolam |
Active Comparator: balanced group General anesthesia is induced with propofol and maintained with desflurane. |
Drug: Balanced Anesthesia |
Ages Eligible for Study: | 19 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620